201 related articles for article (PubMed ID: 28939099)
1. Prognostic and clinical significance of VEGFR-3 in gastric cancer: A meta-analysis.
Ge H; Yan Y; Guo L; He X; Yang X
Clin Chim Acta; 2017 Nov; 474():114-119. PubMed ID: 28939099
[TBL] [Abstract][Full Text] [Related]
2. VEGFR-2 as a novel predictor of survival in gastric cancer: A systematic review and meta-analysis
.
Li T; Yu J; Luo X; Ren W; Zhang Y; Cao B
Pathol Res Pract; 2018 Apr; 214(4):560-564. PubMed ID: 29572120
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic significance of CD24 overexpression in patients with gastric cancer: a meta-analysis.
Wu JX; Zhao YY; Wu X; An HX
PLoS One; 2014; 9(12):e114746. PubMed ID: 25503963
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of CD44 expression in gastric cancer: a meta-analysis.
Chen Y; Fu Z; Xu S; Xu Y; Xu P
Biomed Pharmacother; 2014 Jul; 68(6):693-7. PubMed ID: 25194445
[TBL] [Abstract][Full Text] [Related]
5. Expression of chemokine receptor CCR7 is a negative prognostic factor for patients with gastric cancer: a meta-analysis.
Du P; Liu Y; Ren H; Zhao J; Zhang X; Patel R; Hu C; Gan J; Huang G
Gastric Cancer; 2017 Mar; 20(2):235-245. PubMed ID: 26984468
[TBL] [Abstract][Full Text] [Related]
6. [The expression of VEGF-C, VEGFR-3 and its predictive value on lymph node metastasis and prognosis of gastric cancer].
Han FH; Zhan WH; He YL; Li YM; Zheng ZQ; Peng JS; Cai SR; Ma JP
Zhonghua Wai Ke Za Zhi; 2006 Aug; 44(15):1058-61. PubMed ID: 17074247
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and clinicopathological value of Gli-1 expression in gastric cancer: A meta-analysis.
Lu L; Wu M; Zhao F; Fu W; Li W; Li X; Liu T
Oncotarget; 2016 Oct; 7(42):69087-69096. PubMed ID: 27634907
[TBL] [Abstract][Full Text] [Related]
8. Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis.
Dai M; Yuan F; Fu C; Shen G; Hu S; Shen G
PLoS One; 2017; 12(4):e0175357. PubMed ID: 28403178
[TBL] [Abstract][Full Text] [Related]
9. The clinicopathological and prognostic value of Nanog in human gastrointestinal luminal cancer: A meta-analysis.
Liang C; Zhao T; Ge H; Xu Y; Ren S; Yue C; Li G; Wu J
Int J Surg; 2018 May; 53():193-200. PubMed ID: 29602014
[TBL] [Abstract][Full Text] [Related]
10. CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: a systematic review and meta-analysis.
Yiming L; Yunshan G; Bo M; Yu Z; Tao W; Gengfang L; Dexian F; Shiqian C; Jianli J; Juan T; Zhinan C
Oncotarget; 2015 Dec; 6(39):42019-27. PubMed ID: 26503471
[TBL] [Abstract][Full Text] [Related]
11. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature.
Lei YY; Huang JY; Zhao QR; Jiang N; Xu HM; Wang ZN; Li HQ; Zhang SB; Sun Z
World J Surg Oncol; 2017 Mar; 15(1):68. PubMed ID: 28327158
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of estrogen receptor α and estrogen receptor β in gastric cancer based on a meta-analysis and The Cancer Genome Atlas (TCGA) datasets.
Ge H; Yan Y; Tian F; Wu D; Huang Y
Int J Surg; 2018 May; 53():24-31. PubMed ID: 29555527
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2 expression and patient survival in gastric cancer: a systematic review of the literature with meta-analysis.
Cheng H; Wang X; Li T; Chen L
Med Oncol; 2015 Jan; 32(1):389. PubMed ID: 25428392
[TBL] [Abstract][Full Text] [Related]
14. The Prognostic and Clinicopathological Significance of Tumor-Associated Macrophages in Patients with Gastric Cancer: A Meta-Analysis.
Yin S; Huang J; Li Z; Zhang J; Luo J; Lu C; Xu H; Xu H
PLoS One; 2017; 12(1):e0170042. PubMed ID: 28081243
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of growth factors and growth factor receptors in gastric adenocarcinoma.
Kim JY; Jeon TJ; Bae BN; Kwon JE; Kim HJ; Park K; Shin E
APMIS; 2013 Feb; 121(2):95-104. PubMed ID: 23030255
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of E-cadherin in gastric cancer: a meta-analysis.
Xing X; Tang YB; Yuan G; Wang Y; Wang J; Yang Y; Chen M
Int J Cancer; 2013 Jun; 132(11):2589-96. PubMed ID: 23169395
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma.
Jüttner S; Wissmann C; Jöns T; Vieth M; Hertel J; Gretschel S; Schlag PM; Kemmner W; Höcker M
J Clin Oncol; 2006 Jan; 24(2):228-40. PubMed ID: 16344322
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and prognostic value of preoperative plasma fibrinogen in gastric cancer patients: A meta-analysis.
Cheng F; Zeng C; Zeng L; Chen Y
Medicine (Baltimore); 2019 Oct; 98(40):e17310. PubMed ID: 31577724
[TBL] [Abstract][Full Text] [Related]
19. The prognostic nutritional index is a predictive indicator of prognosis and postoperative complications in gastric cancer: A meta-analysis.
Yang Y; Gao P; Song Y; Sun J; Chen X; Zhao J; Ma B; Wang Z
Eur J Surg Oncol; 2016 Aug; 42(8):1176-82. PubMed ID: 27293109
[TBL] [Abstract][Full Text] [Related]
20. The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis.
Qian H; Appiah-Kubi K; Wang Y; Wu M; Tao Y; Wu Y; Chen Y
Crit Rev Oncol Hematol; 2018 Jul; 127():15-28. PubMed ID: 29891108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]